[go: up one dir, main page]

GT200600450A - Forma cristalina delta de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen - Google Patents

Forma cristalina delta de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen

Info

Publication number
GT200600450A
GT200600450A GT200600450A GT200600450A GT200600450A GT 200600450 A GT200600450 A GT 200600450A GT 200600450 A GT200600450 A GT 200600450A GT 200600450 A GT200600450 A GT 200600450A GT 200600450 A GT200600450 A GT 200600450A
Authority
GT
Guatemala
Prior art keywords
pharmaceutical compositions
compositions containing
preparation procedure
form delta
chlorhydrate
Prior art date
Application number
GT200600450A
Other languages
English (en)
Inventor
Stephane Horvath
Marie-Noelle Auguste
Gerard Damien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36589231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600450(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200600450A publication Critical patent/GT200600450A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A FORMA CRISTALINA DELTA DE CLORHIDRATO DE IVABRADINA LAS CUALES TIENEN PROPIEDADES FARMACOLOGICAS INTERESANTES, EN PARTICULAR PROPIEDADES BRADICARDIZANTES POR LO QUE SON DE UTILIDAD EN CUADROS DE ISQUEMIA MIOCARDICA TALES COMO ANGINA DE PECHO, INFARTO DE MIOCARDIO, ALTERACIONES DEL RITMO, ENTRE OTRAS DESCRITAS EN LA SOLICITUD. T2006
GT200600450A 2005-10-11 2006-10-05 Forma cristalina delta de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen GT200600450A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0510352A FR2891826B1 (fr) 2005-10-11 2005-10-11 Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
GT200600450A true GT200600450A (es) 2007-06-18

Family

ID=36589231

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600450A GT200600450A (es) 2005-10-11 2006-10-05 Forma cristalina delta de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen

Country Status (30)

Country Link
US (3) US7358240B2 (es)
EP (2) EP1775288A1 (es)
JP (1) JP2007112796A (es)
KR (1) KR20070040311A (es)
CN (1) CN1948292A (es)
AP (1) AP2303A (es)
AR (1) AR056572A1 (es)
AU (1) AU2006228027B2 (es)
BR (1) BRPI0604250A (es)
CA (1) CA2564367C (es)
CO (1) CO5790166A1 (es)
CR (1) CR8645A (es)
EA (1) EA010296B1 (es)
EC (1) ECSP066915A (es)
FR (1) FR2891826B1 (es)
GE (1) GEP20094653B (es)
GT (1) GT200600450A (es)
IL (1) IL178544A (es)
MA (1) MA28626B1 (es)
MX (1) MXPA06011766A (es)
MY (1) MY139508A (es)
NO (1) NO20064596L (es)
NZ (1) NZ550435A (es)
PE (1) PE20070492A1 (es)
SA (1) SA06270370B1 (es)
SG (1) SG131858A1 (es)
TW (1) TWI377946B (es)
UA (1) UA90265C2 (es)
WO (1) WO2007042656A1 (es)
ZA (1) ZA200608403B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891827B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP2097383B1 (en) * 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
CN101353325B (zh) * 2007-07-27 2011-11-09 上海优拓医药科技有限公司 稳定型盐酸伊伐布雷定结晶及其制备方法
WO2008146308A2 (en) 2007-05-30 2008-12-04 Ind-Swift Laboratories Limited Process for the preparation of ivabradine hydrochloride and polymorph thereof
CN102264689B (zh) 2008-12-22 2014-12-31 新梅斯托克尔卡公司 制备伊伐布雷定的方法
CN101774969B (zh) 2009-01-13 2012-07-04 江苏恒瑞医药股份有限公司 硫酸伊伐布雷定及其i型结晶的制备方法
SI2902384T1 (en) 2010-02-12 2018-03-30 Krka, D.D., Novo Mesto The form of ivabradine hydrochloride
HUP1000245A2 (en) 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2012025940A1 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Polymorphic form of ivabradine hydrochloride and process for preparation thereof
US9440924B2 (en) 2011-08-02 2016-09-13 Sandoz Ag Acetone solvate of ivabradine hydrochloride
EP2773621B1 (en) 2011-11-04 2015-12-30 Synthon BV A process for making crystalline delta-form of ivabradine hydrochloride
EP2589594A1 (en) * 2011-11-04 2013-05-08 Urquima S.A. Ivabradine hydrochloride Form IV
WO2013102919A1 (en) 2011-11-14 2013-07-11 Cadila Healthcare Limited Polymorphic forms of ivabradine hydrochloride
EP2948432B1 (en) 2013-01-24 2018-09-19 Synthon BV Process for making ivabradine
SI2781509T2 (sl) 2013-03-19 2023-10-30 Chemo Research, S.L. Novi polimorf ivabradin hidroklorida in postopek za njegovo pripravo
CZ2013767A3 (cs) 2013-10-02 2015-04-29 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice
WO2015001133A1 (en) 2013-12-12 2015-01-08 Synthon B.V. Pharmaceutical composition comprising amorphous ivabradine
SI2774606T1 (sl) 2014-02-14 2019-05-31 Synthon B.V. Farmacevtski sestavek, ki obsega polimorf IV ivabradin hidroklorida
CZ2014478A3 (cs) 2014-07-10 2015-09-16 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice
WO2016102423A1 (en) 2014-12-22 2016-06-30 Ratiopharm Gmbh Composition comprising ivabradine in a dissolved form
GR1008821B (el) 2015-06-11 2016-08-01 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
CN107056706B (zh) * 2015-12-21 2020-05-05 江苏恒瑞医药股份有限公司 一种用于制备盐酸伊伐布雷定α晶型的方法
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
TR201703066A2 (tr) 2017-02-28 2018-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi İvabradi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
IT202000025312A1 (it) 2020-10-26 2022-04-26 Cambrex Profarmaco Milano S R L Processi per la preparazione di polimorfi di ivabradina hcl

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9017453D0 (en) 1990-08-09 1990-09-26 Mcivor Robert C Fluid additive regulating apparatus
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CA2504863A1 (en) * 2005-04-21 2006-10-21 Larry J. Chernoff Integrated valve system

Also Published As

Publication number Publication date
CA2564367A1 (fr) 2007-04-11
US20070082885A1 (en) 2007-04-12
UA90265C2 (ru) 2010-04-26
US7867997B2 (en) 2011-01-11
GEP20094653B (en) 2009-03-25
CA2564367C (fr) 2010-05-18
EA010296B1 (ru) 2008-08-29
US20090318419A1 (en) 2009-12-24
CR8645A (es) 2007-06-08
FR2891826B1 (fr) 2007-12-28
TW200800222A (en) 2008-01-01
AP2303A (en) 2011-10-31
SG131858A1 (en) 2007-05-28
AU2006228027B2 (en) 2011-08-25
TWI377946B (en) 2012-12-01
JP2007112796A (ja) 2007-05-10
NZ550435A (en) 2007-12-21
MXPA06011766A (es) 2007-04-10
WO2007042656A1 (fr) 2007-04-19
EA200601662A1 (ru) 2007-04-27
ECSP066915A (es) 2007-05-30
ZA200608403B (en) 2008-06-25
SA06270370B1 (ar) 2010-03-23
PE20070492A1 (es) 2007-06-23
AR056572A1 (es) 2007-10-10
MA28626B1 (fr) 2007-06-01
EP1956005A1 (fr) 2008-08-13
IL178544A (en) 2017-04-30
IL178544A0 (en) 2007-02-11
CN1948292A (zh) 2007-04-18
KR20070040311A (ko) 2007-04-16
EP1775288A1 (fr) 2007-04-18
US7358240B2 (en) 2008-04-15
AP2006003762A0 (en) 2006-10-31
US20080161284A1 (en) 2008-07-03
FR2891826A1 (fr) 2007-04-13
AU2006228027A1 (en) 2007-04-26
NO20064596L (no) 2007-04-12
MY139508A (en) 2009-10-30
BRPI0604250A (pt) 2007-08-21
CO5790166A1 (es) 2007-08-31

Similar Documents

Publication Publication Date Title
GT200600450A (es) Forma cristalina delta de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen
GT200600448A (es) Forma cristalina delta-d de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen
JOP20180103B1 (ar) التركيب الصيدلاني للكاربيتوسين
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
GT200600084A (es) Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
ECSP066715A (es)
MX373230B (es) Composición farmacéutica y su administración.
MX339402B (es) Composiciones y metodos que comprenden variantes de serina proteasa.
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
EP2367571A4 (en) NOVEL LIPIDS AND NEW COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS
CO6680663A2 (es) Composiciones pesticidas producidas de piranosas, composiciones que las contienen y su proceso de obtención
DOP2011000229A (es) Composicion farmaceutica solida que comprende amlodipina y losartan
CO6341618A2 (es) 4-fenil-1h-pirazoles insecticidas
GT200600347A (es) Nueva formula cristalina iii de la agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que la contienen
GT200500314A (es) Formulaciones
BR112012012862A2 (pt) composição farmacêutica compreendendo oligopeptídeos
BR112014009376A2 (pt) composições
BRPI0915560A2 (pt) composições e processos de fabricação de composições
DOP2009000262A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
SV2006002384A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
GT200500130A (es) Forma cristalina alfa del ranelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
GT200600048A (es) Pirroles sustituidos, composiciones que los contienen, proceso de fabricación y utilización.
CL2012000393A1 (es) Compuestos octasacaridos n-acilados; composicion farmaceutica; intermediarios; utiles en el tratamiento de enfermedades tales como isquemia, angina de pecho, aterosclerosis, entre otras.